These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 813284)
1. Reduction in infarct size following experimental coronary occlusion by administration of verapamil. Singh BN; Smith HJ; Norris RM Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284 [TBL] [Abstract][Full Text] [Related]
2. Effects of verapamil on infarct size following experimental coronary occlusion. Smith HJ; Singh BN; Nisbet HD; Norris RM Cardiovasc Res; 1975 Jul; 9(4):569-78. PubMed ID: 1182734 [TBL] [Abstract][Full Text] [Related]
3. The effect of verapamil on experimental myocardial ischaemia with a particular reference to regional myocardial blood flow and metabolism. Smith HJ; Singh BN; Norris RM; Nisbet HD; John MB; Hurley PJ Aust N Z J Med; 1977 Apr; 7(2):114-21. PubMed ID: 268165 [TBL] [Abstract][Full Text] [Related]
4. [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct]. Kötter V; Leitner Ev; Arbeiter G; Cordes R; Schröder R Z Kardiol; 1975 Jul; 64(7):672-86. PubMed ID: 1163092 [TBL] [Abstract][Full Text] [Related]
5. Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris. Szekeres L; Csik V; Udvary E J Pharmacol Exp Ther; 1976 Jan; 196(1):15-28. PubMed ID: 812980 [TBL] [Abstract][Full Text] [Related]
6. Thoracic epidural anesthesia reduces myocardial infarct size after coronary artery occlusion in dogs. Davis RF; DeBoer LW; Maroko PR Anesth Analg; 1986 Jul; 65(7):711-7. PubMed ID: 3717611 [TBL] [Abstract][Full Text] [Related]
7. Effects of verapamil and nitroglycerin on coronary and systemic hemodynamics in conscious dogs. Adachi H; Tomoike H; Nishijima H; Hayashi Y; Yamada A; Nakamura M J Pharmacol Exp Ther; 1987 Jun; 241(3):1072-8. PubMed ID: 3110406 [TBL] [Abstract][Full Text] [Related]
8. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease. Simonsen S Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073 [TBL] [Abstract][Full Text] [Related]
9. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Reimer KA; Jennings RB Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220 [TBL] [Abstract][Full Text] [Related]
10. Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia. Pearlman AS; Engler RL; Goldstein RA; Kent KM; Epstein SE Eur J Cardiol; 1980; 11(4):295-313. PubMed ID: 6771145 [TBL] [Abstract][Full Text] [Related]
11. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488 [TBL] [Abstract][Full Text] [Related]
12. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog. Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337 [TBL] [Abstract][Full Text] [Related]
13. Vasoactive parathyroid hormone in the treatment of acute ischemic left ventricular failure and the prevention of cardiogenic shock. Feola M; Gonzales H; Canizaro PC Circ Shock; 1985; 17(2):163-77. PubMed ID: 4053300 [TBL] [Abstract][Full Text] [Related]
14. The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog. Uno Y; Minatoguchi S; Arai M; Wang N; Chen XH; Hashimoto K; Lu C; Takemura G; Fujiwara H Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):805-10. PubMed ID: 16173940 [TBL] [Abstract][Full Text] [Related]
15. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. Daniell HB; Privitera PJ; Conradi SE; Gaffney TE J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147 [TBL] [Abstract][Full Text] [Related]
17. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)]. Nakaya H Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455 [TBL] [Abstract][Full Text] [Related]
18. [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction]. Yamamoto T; Katori R J Cardiol; 1995 Sep; 26(3):167-75. PubMed ID: 7473047 [TBL] [Abstract][Full Text] [Related]
19. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion. Becker LC J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534 [TBL] [Abstract][Full Text] [Related]
20. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs. Heng MK; Singh BN; Norris RM; John MB; Elliot R J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]